Urofollitropin is a synthetic hormone used in fertility treatments for
women who are unable to ovulate on their own. It is also known as
follicle-stimulating hormone (FSH) and is responsible for stimulating the
development of eggs in the ovaries. Urofollitropin is available in injection
form and must be administered by a healthcare professional.
Urofollitropin is primarily used in women who are undergoing assisted
reproductive technology (ART) treatments, such as in vitro fertilization (IVF).
It is used to stimulate the ovaries to produce multiple eggs, which are then
collected and fertilized outside the body. Urofollitropin may also be used for
other medical conditions, such as in men with low sperm count.
The dosage and duration of treatment with urofollitropin will vary
depending on the individual patient and the specifics of their fertility
treatment. The medication is typically administered through a subcutaneous
injection, starting on day three of the menstrual cycle and continuing for up to
Like any medication, urofollitropin may cause side effects in some
patients. The most common side effects include headache, abdominal pain, nausea,
and bloating. More serious side effects, such as ovarian hyperstimulation
syndrome (OHSS), are rare but can occur. OHSS is a potentially life-threatening
condition that can cause fluid buildup in the chest and abdomen.
It is important to speak with a healthcare professional before starting any
fertility treatment and to closely monitored throughout the course of treatment
Urofollitropin is a valuable tool in the treatment of infertility in women.
Understanding the proper dosage and potential side effects of this medication is
important for any patient considering fertility treatment. As with any medical
treatment, it is important to work closely with a healthcare professional to
ensure that the best possible treatment plan is in place.